Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01734512 |
| Title | PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of California, San Francisco, Novartis Pharmaceuticals, Pacific Pediatric Neuro-Oncology Consortium |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |